EPI-PHARE participe à la 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, à Philadephie (USA).

Lors de ce congrès, EPI-PHARE présente 3 posters :

• Impact of Levothyrox formulation change on health and healthcare use in France.
• Risk of Hematologic Malignant Neoplasms after post-operative treatment of Breast Cancer
• Potential inappropriate underdosing in patients initiating non-vitamin K oral anticoagulants in France: findings from the national healthcare databases